Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01189 (
beta-endorphin
)
21,003
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Three 3-hr incubations of pars intermedia cells from 40 rat pituitaries with [35S]methionine, [3H]lysine, and [3H]leucine sufficed for the identification and chemical characterization of biosynthesized beta-lipotropin, gamma-lipotropin, and
beta-endorphin
. From the molecular weight, migration on polyacrylamide gels, and sequence Met5, Lys9, Leu14,17, rat
beta-endorphin
was shown to be identical to its sheep homologue and no trace of Leu5
beta-endorphin
could be detected. Rat beta-lipotropin differs from that of sheep in its elution properties on CM-cellulose, and its sequence shows
Leu2
,10,14, Lys20. Rat gamma-lipotropin shows the same NH2-terminal sequence as beta-lipotropin and is again different from its sheep homologue. The identification of rat beta-lipotropin was confirmed by its selective cleavage into
beta-endorphin
after trypsin digestion of the citraconylated peptide, a property not observed with rat gamma-lipotropin.
...
PMID:In vitro biosynthesis and chemical characterization of beta-lipotropin, gamma-lipotropin, and beta-endorphin in rat pars intermedia. 27 17
Pretreatment of mice with a single injection of morphine,
beta-endorphin
, Leu-enkephalin, FK33824 or [D-Ala2-D-Leu5]enkephalin, for 3 h increased the ability of naloxone to antagonize the analgesic effects of morphine. However, dynorphin-(1-13) can only antagonize morphine,
beta-endorphin
or Leu-enkephalin induced increased naloxone efficacy but not FK33824 or [D-Ala2-D-
Leu2
]enkephalin. Dynorphin itself can also increase naloxone efficacy when treated alone. However, this effect can be prevented when animals are pretreated with dynorphin and naloxone together.
...
PMID:Possible regulatory role of dynorphin-(1-13) on narcotic-induced changes in naloxone efficacy. 627 44